CD82 and prostate cancer: CD82 has been shown to promote enhanced cell to cell adhesion through E-cadherin in epithelial cells, i.e., CD82 expression in prostate cancer cells promoted E-cadherin-induced adhesion strongly by stabilizing E-cadherin’s association with β-catenin, a complex required for E-cadherin function and stability [41].